There are a lack of women at venture capital firms. This makes it difficult for women's health startups focused on stigmatized conditions to get funding when pitching to those who don't always have a good understanding, startups say.
Allara raised $10 million in a Series A funding round led by GV. The startup offers membership-based virtual services to treat women's chronic hormonal conditions, such as PCOS and endometriosis. CEO Rachel Blank — former executive at Ro and investor at General Catalyst — founded the company partly due to the difficulty she experienced arriving at her own PCOS diagnosis.
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
Rachel Blank, former director of strategy at digital health unicorn Ro, left to start her own digital health company. Her new startup, Allara is focused on helping people manage polycystic ovary syndrome (PCOS).